Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV

  • Read more about Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV
US Application 62/209,619
Filed on 2015-08-25

Substituted Phenylpyrrolecarboxamides With Therapeutic

  • Read more about Substituted Phenylpyrrolecarboxamides With Therapeutic
US Application 62/209,268
Filed on 2015-08-24

CD153 AND MYCOBACTERIUM TUBERCULOSIS INFECTION

  • Read more about CD153 AND MYCOBACTERIUM TUBERCULOSIS INFECTION
US Application 62/633,816
Filed on 2018-02-22

Antibodies and Methods for the Diagnosis, Prevention, and Treatment of Epstein Barr Virus Infection

  • Read more about Antibodies and Methods for the Diagnosis, Prevention, and Treatment of Epstein Barr Virus Infection
US Application 62/665,977
Filed on 2018-05-02

COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF

  • Read more about COMPOSITIONS COMPRISING PREGNANCY SPECIFIC GLYCOPROTEINS AND METHODS OF USE THEREOF
US Application 62/219,900
Filed on 2015-09-17

TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS

  • Read more about TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS
US Application 62/710,339
Filed on 2018-02-16

NIPAH VIRUS IMMUNOGENS AND THEIR USE

  • Read more about NIPAH VIRUS IMMUNOGENS AND THEIR USE
US Application 62/714,230
Filed on 2018-08-03

Methods Of Treating And Inhibiting Ebola Virus Infection

  • Read more about Methods Of Treating And Inhibiting Ebola Virus Infection
US Application 62/420,474
Filed on 2016-11-10

BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE

  • Read more about BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE
US Application 62/620,051
Filed on 2018-01-22

UNIVERSAL INFLUENZA VIRUS PROBE SET FOR ENRICHMENT OF ANY INFLUENZA VIRUS NUCLEIC ACID

  • Read more about UNIVERSAL INFLUENZA VIRUS PROBE SET FOR ENRICHMENT OF ANY INFLUENZA VIRUS NUCLEIC ACID
US Application 62/611,734
Filed on 2017-12-29

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 53
  • Page 54
  • Page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • Page 60
  • Page 61
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health